KDIGO
KDIGO is a global organization dedicated to improving patient outcomes in kidney disease through the development and implementation of clinical practice guidelines and resources. https://www.kdigo.org
SGLT2 Inhibitors and GLP-1 Receptor Agonists: Different Classes, Different Modes of Kidney Protection
By
KDIGO
FEATURING
Hiddo Lambers Heerspink
By
KDIGO
FEATURING
Hiddo Lambers Heerspink
Original Recording Date: 4/18/2021
Login to view comments.
Click here to Login
